Vinge has advised Oncopeptides in connection with entering into agreements regarding a loan facility of up to EUR 40 million from the EIB

The loan agreement with the EIB grants Oncopeptides access to an unsecured loan facility of up to EUR 40 million. The loan may be used to further support the clinical development of melflufen and the company’s transition from a R&D company into a fully integrated global biopharmaceutical company. In connection with the loan agreement, Oncopeptides has entered into a warrant agreement with the EIB, entitling the EIB to warrants in the company should the company draw on the loan facility.

Vinge advises Axcel VI in connection with the three parallel acquisitions of Installationsgruppen, Ventab and Ventilationsprojekt

Vinge has advised Axcel VI in connection with the three parallel acquisitions of Installationsgruppen Partners AB, Ventab Partners AB and Ventilationsprojekt i Sverige AB, which creates a leading installation group within HVAC, sprinkler and building automation.

Vinge advises Amasten on its offer for SSM

Vinge advises Amasten Fastighets AB (publ) in connection with its public offer to the shareholders of SSM Holding AB (publ) (“SSM”)

Vinge advises Cell Impact AB (publ) in connection with a directed share issue

Vinge has advised Cell Impact AB (publ) in connection with a directed share issue, whereby Cell Impact receives proceeds of SEK 175 million.

Vinge advised Nextmune in connection with its acquisition of I.C.F. S.r.l and D.R.N. S.r.l.

Vinge has advised Fidelio Capital and its portfolio company Nextmune, a leading science driven, global specialty pharmaceutical company dedicated to improving health for dogs, cats and horses, in connection with its acquisition of I.C.F. S.r.l and D.R.N. S.r.l.

Vinge has advised the arranging banks in connection with Svenska Handelsbanken’s issue of Additional Tier 1 Capital Contingent Convertible (AT1) in the amount of MUSD 1000 

Vinge has advised Morgan Stanley & Co. International plc and the other arranging banks consisting of Barclays Bank PLC, Citigroup Global Markets Limited, J.P. Morgan Securities plc and Svenska Handelsbanken AB (publ) in respect of Swedish law in connection with Svenska Handelsbanken’s issue of Additional Tier 1 Contingent Convertible Notes (AT1 CoCo). The issuance amount is USD 1,000 million in two tranches of USD 500 million each, at interest rates of 4.375 and 4.75 per cent respectively.

Vinge advises G-Loot in its half a billion SEK financing round

Vinge has advised the esports company G-Loot Global Esports AB (publ) in connection with its financing round of SEK 500 million - one of the largest esports fundraises globally.

Vinge advises Nabo in the acquisition of BoNea and Akevo

Vinge has advised Nabo, a comprehensive supplier of administration and management services to housing cooperative associations in its acquisition of BoNea and Akevo.

Vinge advises Smart Eye in conjunction with a directed new issue of shares

Vinge has advised Smart Eye AB in connection with a directed new issue of 1 511 898 new shares at a subscription price of SEK 125 per share, which means that Smart Eye will acquire MSEK 189 prior to issue costs.

Vinge advises on the sale of Advanced Technology Solutions

Vinge has advised on the sale of Advanced Technology Solutions in Scandinavia AB, ATS.

The European Investment Bank has signed a EUR 47 million financing agreement with Swedish innovative battery technology company Nilar.

Vinge has acted as European Investment Bank’s (the EIB) counsel in the financing of the battery technology company Nilar International AB (Nilar).

Vinge advises Schwarz Group on the market entry of its environmental division PreZero in Sweden in connection with PreZero's acquisition of SUEZ’s waste management and recycling operations in Sweden.

SUEZ has more 50 recycling sites and around 1,000 employees in Sweden.

Vinge advises Direktronik in conjunction with the acquisition of Nexlan

Vinge has advised Lagercrantz Group AB’s subsidiary Direktronik AB in conjunction with the acquisition of all shares in the Norwegian company Nexlan AS.

Vinge advises Internationella Engelska Skolan in connection with mandatory cash offer

On 25 September 2020, Grundstenen 300029 AB, owned by a consortium led by Paradigm Capital Value Fund SICAV, as well as Paradigm Capital Value LP, The Hans and Barbara Bergström Foundation, AB Tuna Holding, certain investors which are advised by Paradigm Capital AG (investment advisor to Paradigm Capital SICAV) and certain investors who have previously not been shareholders of Internationella Engelska Skolan (“IES”), announced, a mandatory cash offer to the shareholders of IES to acquire all shares in IES.

Vinge advises EQT VIII in connection with the acquisition of Schülke & Mayr GmbH

Vinge has advised EQT VIII on the merger control aspects of EQT VIII’s acquisition of Schülke & Mayr GmbH, a provider of infection prevention solutions. The acquisition was notified to, inter alia, the European Commission.